New York (MedscapeWire) Mar 2 — In patients with Parkinson's disease and psychosis who failed treatment with other atypical antipsychotic agents, quetiapine (Seroquel, AstraZeneca) improved both ...

The XR in SEROQUEL XR stands for extended release. This means that medication is released around the clock. SEROQUEL XR is taken once daily as prescribed by your health care professional. SEROQUEL XR ...

December 7, 2009 — The US Food and Drug Administration (FDA) has approved a new indication for quetiapine fumarate extended-release tablets (Seroquel XR, AstraZeneca Pharmaceuticals, LP), allowing ...

Current Primary Outcome Measures •Percentage of Participants with Response (>=50 Percent improvement in MADRS total score from baseline) at Week 26 [ Time Frame: Week 26 ] -- Responders are defined as ...

NEW YORK CITY -- Patients with borderline personality disorder showed significant improvements when treated with long-acting antipsychotic agent quetiapine fumarate (Seroquel XR) in a ...

Alderley Park, UK, 17 June 2005 – A new study, published today in the journal Human Psychopharmacology: Clinical and Experimental, 1 shows that the atypical antipsychotic SEROQUEL (quetiapine), may be ...

Augmentation was more effective with quetiapine than lithium for treatment-resistant depression in a pragmatic trial. Quetiapine also improved quality-adjusted life years more than lithium. The ...

Nasal esketamine spray is more effective than an extended-release antipsychotic, when both are taken in combination with SSRIs and SNRIs, in patients with depressive episodes that didn’t respond to ...

LONDON, Nov. 13, 2008-AstraZeneca today announced that the once-daily formulation SEROQUEL XR (quetiapine fumarate extended release tablets) and SEROQUEL (quetiapine fumarate) have been approved under ...

SEROQUEL XR is Now Approved to Treat the Depressive, Manic, and Mixed Episodes of Bipolar Disorder WILMINGTON, Del., Feb. 23 /PRNewswire-FirstCall/ -- AstraZeneca ...